For both CD and UC, patients entering as prolonged corticosteroid users were older and had poorer health than new anti-TNF users, including higher number of comorbidities, more non–IBD-associated medications, and higher rates of non–IBD-related hospitalizations. The gene discussed is TNF; the disease is inflammatory bowel disease.